Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for maintaining blood sugar, fluid/electrolyte levels, and normal pubertal development. Current methods to monitor CAH are expensive and have a long turnaround time. Our goal is to develop an assay to measure hormone levels that is accurate, easy, and cost-effective. In doing so, we aim to serve these patients both in managing their medical needs and developing new ways to reduce the cost of care.